How should a lacosamide tablet ingestion be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Lacosamide Tablet Ingestion

Lacosamide overdose should be managed with supportive care focused on airway protection, cardiac monitoring for sodium channel blockade effects (QRS prolongation, dysrhythmias), seizure control with benzodiazepines, and consideration of sodium bicarbonate for life-threatening cardiotoxicity.

Initial Assessment and Monitoring

Immediately assess and secure the airway, as lacosamide overdose commonly causes CNS depression ranging from drowsiness to coma requiring intubation in approximately one-third of cases 1. The median toxic dose in reported cases is 1500 mg, with coma occurring at significantly higher doses (median 2800 mg) 1.

Establish continuous cardiac monitoring to detect sodium channel blockade manifestations, which are the most life-threatening complications:

  • QRS prolongation
  • Terminal R-wave in lead aVR >3 mm
  • PR interval prolongation
  • Ventricular dysrhythmias including ventricular tachycardia and cardiac arrest 2, 3

Monitor vital signs closely for bradycardia (9.7% of cases), tachycardia (12.9%), and hypotension 1.

Specific Management Interventions

Sodium Bicarbonate for Cardiotoxicity

Administer hypertonic sodium bicarbonate for life-threatening cardiotoxicity (QRS prolongation, ventricular dysrhythmias, cardiac arrest), as lacosamide is a sodium channel blocker similar to tricyclic antidepressants 4. While the evidence for sodium bicarbonate in lacosamide toxicity specifically is limited to case reports 3, the 2023 AHA guidelines strongly recommend its use for sodium channel blocker poisoning with cardiotoxicity 4.

  • Adult dose: 1-2 mEq/kg (typically 50-100 mEq) IV bolus, repeated as needed
  • Pediatric dose: 1-2 mEq/kg IV bolus
  • Target serum pH: 7.50-7.55

Seizure Management

Treat seizures with benzodiazepines as first-line therapy 4. Seizures occur in 29% of lacosamide overdoses 1. The paradox of an antiepileptic drug causing seizures in overdose reflects sodium channel blocker toxicity.

  • Diazepam or lorazepam IV/IM
  • Midazolam if IV access unavailable
  • Do NOT use lacosamide itself to treat overdose-related seizures

Supportive Care Priorities

Provide aggressive supportive care as all reported cases have resulted in full recovery with appropriate management 1, 5:

  • Airway protection: Intubate for coma (occurs in 25.8% of cases), refractory seizures, or inability to protect airway 1
  • Aspiration precautions: Aspiration pneumonia has been reported 5
  • Fluid resuscitation: For hypotension
  • Gastric decontamination: Generally not recommended unless presentation is within 1 hour of massive ingestion and airway is protected

Clinical Course and Monitoring Duration

Lacosamide has a half-life of approximately 13 hours. Cardiac conduction abnormalities may persist for 8+ hours despite sodium bicarbonate therapy 3. Monitor patients for at least 24 hours with continuous cardiac telemetry and serial ECGs until QRS normalization occurs.

Common symptoms by frequency 1:

  • Vomiting (29%)
  • Seizures (29%)
  • Coma (25.8%)
  • Drowsiness (25.8%)
  • Confusion and agitation (12.9% each)

Critical Pitfalls to Avoid

Do not use flumazenil if benzodiazepine co-ingestion is suspected, as it may precipitate seizures in patients with underlying seizure disorders 4.

Recognize polypharmacy: In 64.5% of lacosamide overdoses, co-ingestants are present, most commonly benzodiazepines and valproic acid 1. Other sodium channel blockers (cyclobenzaprine, other antiepileptics) may have synergistic cardiotoxic effects 3.

Do not rely on lacosamide levels for acute management decisions. While therapeutic levels are 10-20 μg/mL, toxic levels (e.g., 22.8 μg/mL) 3 do not directly guide treatment—clinical presentation and ECG findings should drive management.

Disposition

All symptomatic patients require ICU admission. Asymptomatic patients with intentional ingestions should be observed for at least 24 hours given the delayed onset of symptoms and prolonged half-life. Psychiatric evaluation is mandatory for intentional ingestions before discharge.

Prognosis is excellent with appropriate supportive care—complete recovery without sequelae is expected even after massive overdoses (up to 12 grams reported) 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.